TMRW Life Sciences, creator of the automated specimen management platform for frozen eggs and embryos used for in vitro fertilization (IVF) is launching “the world’s most advanced” cryostorage facility, as the company says.

Powered by TMRW’s proprietary technology and supported by round-the-clock monitoring, specimens are stored with extensive real-time data capture and reporting, delivering peace of mind to patients and clinics at all times. TMRW will be expanding its network of technology-enabled cryostorage facilities in both California and the United Kingdom over the coming months.

Central to TMRW’s mission is its ability to uniquely identify, track and trace cryopreserved fertility specimens, whether located in a clinic during active treatment, or offsite in one of their cryobanks after treatment has been completed. The TMRW integrated hardware and software system utilizes state-of-the-art digital identification and tracking to check specimens into and out of storage, creating a complete and secure specimen record and audit trail, providing a level of transparency to patients previously unavailable.

“We are committed to providing a safe, transparent and digitally-enabled solution for both patients and clinics in the care and management of these incredibly precious specimens. We believe the same level of visibility should exist in the care of frozen eggs and embryos as it does in almost all other aspects of our lives today,” said Tara Comonte, TMRW’s chief executive officer. “The extension of our technology from an in-clinic solution to a direct-to-patient offsite state-of-the-art facility has always been a natural evolution. Clinics, and now patients, have a choice, and we’re laser focused on making sure they all sleep better at night with their specimens under our watch.”

The CCRM Fertility network, Conceptions Reproductive Associates, and Illume Fertility are some of the first to take advantage of TMRW’s cryobank and digitally-connected specimen management platform.

“Partnering with TMRW means we’re using the highest standards of technology with a full digital chain of custody to track and trace specimens 24 hours a day, 365 days a year,” said Glenn Proctor, chief operating officer at Conceptions. “TMRW’s platform represents a new standard in our field; this technology provides the most sophisticated, advanced level of control and visibility that exists today.” 

The growing demand for fertility treatment has resulted in an exponential increase in the number of frozen specimens under clinic management, each of which need to be accurately identified, managed and monitored. IVF clinics were not designed to be long-term cryobanks, yet that’s what they’ve inadvertently become.

TMRW’s system reduces the number of opportunities for human error by automating processes and workflows in an integrated digital platform. It provides patients and clinics real-time visibility into their entire cryospecimen inventory, whether on or offsite, and enables highly skilled embryologists to focus on what they do best – helping their patients pursue their dreams of parenthood.

TMRW plans to continue to expand their platform across the United States and Europe throughout 2023.

Show CommentsClose Comments

Leave a comment